Recent events have changed bioterrorism from a theoretical threat into an immediate one; weneed tools for dealing with bioterrorism when it occurs.

Indian bureaucrats and politicians must overcome short-term thinking and improve India's IP systems by ensuring that deserving products receive patents and making sure trademarks are enforced. Only then will India develop a true innovation economy.

Controversies surrounding pharmaceutical patents and trade rules in the WTO

Pharmaceutical patents, drug prices, and parallel imports of drugs from lower-income to higher-income nations have been at the center of some of the most contentious debates in the run-up to Cancun. This panel will analyze the positions of the various protagonists...

India is on the brink of finalizing a free trade agreement with the European Union. Yet even as the deal gets close, one area remains hotly contested: protection for intellectual property (IP). Controversy mounts over "data exclusivity" for pharmaceuticals.

As regulators seek to weigh the potential benefits and risks of a new medicine, my own observation is that they tend to be both tentative and ultra-paternalistic.

Congress is in the process of rewriting the United States' patent laws. Scientific and technological changes in virtually all markets have dramatically altered the patent system itself. Reacting to fears that patents and patent litigation could retard rather than support technological progress, legislators are poised to take action with the...

Do patents matter? And especially, do they matter as a way for inducing private pharmaceutical companies to develop new products that are primarily demanded in third-world countries? As illustrated in a recent special series of articles in the Washington Post, the answers to these questions present policy issues that...

Adoption of a stakeholder approach is likely to undermine essentialresearch and developmentwhile doing little to curtail the HIV/AIDS epidemic.